Mei, Husheng
19  results:
Search for persons X
?
1

Discovery of IHMT-337 as a potent irreversible EZH2 inhibit..:

Mei, Husheng ; Wu, Hong ; Yang, Jing...
Signal Transduction and Targeted Therapy.  8 (2023)  1 - p. , 2023
 
?
2

Discovery of dihydropyridinone derivative as a covalent EZH..:

Zhou, Bin ; Wang, Beilei ; Zou, Fengming...
European Journal of Medicinal Chemistry.  261 (2023)  - p. 115825 , 2023
 
?
6

Discovery of IHMT-EZH2-115 as a Potent and Selective Enhanc..:

Zhou, Bin ; Liang, Xiaofei ; Mei, Husheng...
Journal of Medicinal Chemistry.  64 (2021)  20 - p. 15170-15188 , 2021
 
?
7

Repurposing clinically available drugs and therapies for pa..:

Xue, Yiying ; Mei, Husheng ; Chen, Yisa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183156/.  , 2023
 
?
8

Discovery of IHMT-337 as a potent irreversible EZH2 inhibit..:

Mei, Husheng ; Wu, Hong ; Yang, Jing...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841011/.  , 2023
 
?
9

Heat shock proteins: Biological functions, pathological rol..:

Hu, Chen ; Yang, Jing ; Qi, Ziping...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345296/.  , 2022
 
?
 
?
13

Discovery of IHMT-EZH2-115 as a Potent and Selective Enhanc..:

Bin Zhou (84959) ; Xiaofei Liang (843086) ; Husheng Mei (11581149)...
https://figshare.com/articles/dataset/Discovery_of_IHMT-EZH2-115_as_a_Potent_and_Selective_Enhancer_of_Zeste_Homolog_2_EZH2_Inhibitor_for_the_Treatment_of_B-Cell_Lymphomas/16832778.  , 2021
 
?
14

Discovery of IHMT-EZH2-115 as a Potent and Selective Enhanc..:

Bin Zhou (84959) ; Xiaofei Liang (843086) ; Husheng Mei (11581149)...
https://figshare.com/articles/journal_contribution/Discovery_of_IHMT-EZH2-115_as_a_Potent_and_Selective_Enhancer_of_Zeste_Homolog_2_EZH2_Inhibitor_for_the_Treatment_of_B-Cell_Lymphomas/16832772.  , 2021
 
?
15

Discovery of IHMT-EZH2-115 as a Potent and Selective Enhanc..:

Bin Zhou (84959) ; Xiaofei Liang (843086) ; Husheng Mei (11581149)...
https://figshare.com/articles/dataset/Discovery_of_IHMT-EZH2-115_as_a_Potent_and_Selective_Enhancer_of_Zeste_Homolog_2_EZH2_Inhibitor_for_the_Treatment_of_B-Cell_Lymphomas/16832775.  , 2021
 
1-15